Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

A look at how Kennedy convinced Sen. Cassidy, a doctor and vaccination advocate, that he should become health secretary.

GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Similar to the Democratic senators who have come out forcefully against Kennedy, Cassidy, in an interview with Fox News ...

Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths ...

Discover a clinical trial that was conducted to evaluate the efficacy and safety of autologous HBV vaccine-pulsed dendritic cells and their induced T cells.

Robert F. Kennedy Jr.'s second confirmation hearing highlights vaccine skepticism, bipartisan concerns, and his plans as health secretary nominee.

The final round of committee hearings for Kennedy’s bid to be HHS Secretary was contentious from the start.

Kirk: “Is a hepatitis B vaccine really necessary for every newborn child? Is that really necessary? Do we really need to ...